PRICE T ROWE ASSOCIATES INC /MD/ - OVID THERAPEUTICS INC ownership

OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 68 filers reported holding OVID THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of OVID THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$52
+30.0%
13,414
+10.7%
0.00%
Q2 2023$40
-43.7%
12,113
-56.0%
0.00%
Q1 2023$71
+39.2%
27,5000.0%0.00%
Q4 2022$51
-99.9%
27,5000.0%0.00%
Q3 2022$51,000
-23.9%
27,500
-11.7%
0.00%
Q2 2022$67,000
-43.7%
31,133
-18.0%
0.00%
Q1 2022$119,000
-2.5%
37,9610.0%0.00%
Q4 2021$122,000
-4.7%
37,9610.0%0.00%
Q3 2021$128,000
-13.5%
37,9610.0%0.00%
Q2 2021$148,0000.0%37,961
+3.3%
0.00%
Q1 2021$148,000
-89.7%
36,748
-80.1%
0.00%
Q2 2018$1,442,000
-32.1%
184,811
-38.5%
0.00%
Q1 2018$2,124,000
-28.2%
300,480
+0.3%
0.00%
Q4 2017$2,957,000
-0.5%
299,570
-17.2%
0.00%
-100.0%
Q3 2017$2,971,000
-18.3%
361,6400.0%0.00%0.0%
Q2 2017$3,637,000361,6400.00%
Other shareholders
OVID THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 4,006,185$12,860,0005.90%
GLOBEFLEX CAPITAL L P 2,794,834$8,972,0000.92%
BVF INC/IL 6,631,051$21,286,0000.77%
EcoR1 Capital, LLC 6,082,200$19,524,0000.62%
CHI Advisors LLC 400,000$1,284,0000.43%
Ikarian Capital, LLC 705,082$2,264,0000.34%
Artal Group S.A. 2,500,000$8,025,0000.22%
DCF Advisers, LLC 141,701$455,0000.18%
PLATINUM INVESTMENT MANAGEMENT LTD 766,901$2,462,0000.07%
ACADIAN ASSET MANAGEMENT LLC 2,040,084$6,543,0000.02%
View complete list of OVID THERAPEUTICS INC shareholders